" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
Clinical trial NCT06602557 · RECRUITING
Trial details
- NCT number
- NCT06602557
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2028-08-10
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.